Personalized Medicine News and Research

RSS

First-of-its-kind study combines smoking cessation with personalized medicine

A simple blood test is allowing Vanderbilt University Medical Cente researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.

20 Nov 2017

New technique holds promise to screen cancer cells for drug susceptibility

Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to months of treatment with a drug that isn't working.

20 Nov 2017

Researchers map first-ever proteome of healthy human heart

A healthy heart beats about two billion times during a lifetime – thanks to the interplay of more than 10,000 proteins. Researchers from the Max Planck Institute of Biochemistry and the German Heart Centre at the Technical University of Munich have now determined which and how many individual proteins are present in each type of cell that occurs in the heart.

17 Nov 2017

Analysis finds simple method to identify patients most likely to benefit from long-term canakinumab treatment

A new analysis seeks to answer the question of which patients are likely to gain the greatest cardiovascular benefit when treated with the anti-inflammatory agent canakinumab.

14 Nov 2017

3D cultured spheroids could drive precision treatment for ovarian cancer

Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.

9 Nov 2017

UA Cancer Center researchers delve deeper into benefits and harms of selenium supplementation

Personalized medicine -- health care tailored to the individual patient -- not only involves the use of prescription medications but vitamins and supplements as well.

8 Nov 2017

Poor white matter health may contribute to persistent musculoskeletal pain in Gulf War veterans

A study from the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin, has shown that structural damage in the white matter of the brain may be linked to chronic musculoskeletal pain in Gulf War veterans.

1 Nov 2017

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

In many metastasized types of cancer, disseminated tumors grow back despite successful chemotherapy. As a research team under the direction of the University of Bern, Switzerland, has now discovered, this is because of isolated cancer cells that survive the chemotherapy due to a phase of dormancy.

27 Oct 2017

Queen's University Belfast leads new research to better understand biology of prostate cancer

Queen's University Belfast has led the world's largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumors, which could lead to a transformation in how prostate cancer is diagnosed and treated.

23 Oct 2017

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

The Photoelectric Therapy System is a compact and ergonomic superficial X-Ray therapy system operating in the 10 kV to 80 kV range intended for superficial radiotherapy and surface electronic brachytherapy treatment of primary malignant epithelial neoplasms of the skin and keloids.

From Xstrahl 19 Oct 2017

CHOP researchers discover key differences among gene fusions in childhood brain tumors

Researchers investigating pediatric low-grade gliomas, the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer.

17 Oct 2017

Survey highlights major gap in women’s knowledge about genomic testing in breast cancer

Breast cancer is the most feared type of cancer among women in Germany, according to a recent representative survey commissioned by Agendia, a world leader in personalized medicine and molecular cancer diagnostics.

11 Oct 2017

New body-on-a-chip system holds potential for advanced drug screening

Using the same expertise they've employed to build new organs for patients, scientists at Wake Forest Institute for Regenerative Medicine and colleagues have engineered micro hearts, lungs and livers that can potentially be used to test new drugs. By combining the micro-organs in a monitored system, the researchers aim to mimic how the human body responds to medications.

5 Oct 2017

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training - that is, learning to perform well under low-oxygen conditions.

18 Sep 2017

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.

18 Sep 2017

Myriad Genetics presents positive results of new hereditary cancer test at 36th annual conference of NSGC

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that two important studies will be featured in podium presentations at the 36th annual conference of the National Society of Genetic Counselors in Columbus, OH.

18 Sep 2017

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, is working to educate the public about hereditary cancer risk assessment and testing during Prostate Cancer Awareness Month this September.

11 Sep 2017

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the ARIEL3 trial reported today at the ESMO 2017 Congress in Madrid.

8 Sep 2017

Myriad Genetics introduces new precision medicine tool to enhance myRisk Hereditary Cancer test

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.

7 Sep 2017

Antidepressants used for chronic pain relief come with significant side effects

Chronic pain negatively impacts a person's quality of life. Often, over the counter pain medication, such as ibuprofen or aspirin, are ineffective in alleviating chronic pain. In these instances, a surprising choice is often a drug used to treat an entirely different condition - depression.

5 Sep 2017

Personalized Medicine News and Research

First-of-its-kind study combines smoking cessation with personalized medicine

New technique holds promise to screen cancer cells for drug susceptibility

Researchers map first-ever proteome of healthy human heart

Analysis finds simple method to identify patients most likely to benefit from long-term canakinumab treatment

3D cultured spheroids could drive precision treatment for ovarian cancer

UA Cancer Center researchers delve deeper into benefits and harms of selenium supplementation

Poor white matter health may contribute to persistent musculoskeletal pain in Gulf War veterans

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

Queen's University Belfast leads new research to better understand biology of prostate cancer

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

CHOP researchers discover key differences among gene fusions in childhood brain tumors

Survey highlights major gap in women’s knowledge about genomic testing in breast cancer

New body-on-a-chip system holds potential for advanced drug screening

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Myriad Genetics presents positive results of new hereditary cancer test at 36th annual conference of NSGC

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Myriad Genetics introduces new precision medicine tool to enhance myRisk Hereditary Cancer test

Antidepressants used for chronic pain relief come with significant side effects

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News